Login / Signup

Efficacy and Safety of Eravacycline in Obese Patients: A Post Hoc Analysis of Pooled Data From the IGNITE1 and IGNITE4 Clinical Trials.

Tomefa E AsempaSergey IzmailyanKenneth LawrenceDavid P Nicolau
Published in: Open forum infectious diseases (2020)
This post hoc analysis demonstrates the therapeutic utility and acceptable safety profile of eravacycline dosed by ABW in obese patients (BMI ≥30 kg/m2).
Keyphrases